Last fall, FDA inspectors found multiple safety and quality issues at one of the manufacturing sites Novo Nordisk has agreed to purchase, according to a Feb. 6 Bloomberg report.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
